254 related articles for article (PubMed ID: 2741811)
21. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
Wehr M
Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
[TBL] [Abstract][Full Text] [Related]
22. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
23. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W
Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757
[TBL] [Abstract][Full Text] [Related]
26. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
27. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Dorian P; Newman D; Berman N; Hardy J; Mitchell J
J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
[TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias.
Kehoe RF; Zheutlin TA; Dunnington CS; Mattioni TA; Yu G; Spangenberg RB
Am J Cardiol; 1990 Jan; 65(2):58A-64A; discussion 65A-66A. PubMed ID: 2294689
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
Lee SD; Newman D; Ham M; Dorian P
J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
[TBL] [Abstract][Full Text] [Related]
34. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
36. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
[TBL] [Abstract][Full Text] [Related]
37. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
Aliot E; Sadoul N; De Chillou C
Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
39. Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation.
Oikarinen L; Viitasalo M; Toivonen L
Am J Cardiol; 1998 Mar; 81(6):694-7. PubMed ID: 9527076
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias.
Garan H; Ruskin JN; DiMarco JP; Derkac WM; Akins CW; Daggett WM; Austen WG; Buckley MJ
Am J Cardiol; 1983 Feb; 51(3):519-24. PubMed ID: 6600577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
